Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Most COVID-19 cases in Massachusetts outbreak among vaccinated, says CDC

07/30/2021 | 02:38pm EDT

July 30 (Reuters) - Three-quarters of people infected with COVID-19 at July public events in a town on Cape Cod in Massachusetts were fully vaccinated, a study by the U.S. Centers for Disease Control and Prevention (CDC) showed.

The study, published on Friday, suggested the Delta variant of the virus was highly contagious. The outbreak occurred in Provincetown on Cape Cod, according to Barnstable County health authorities.

The CDC study found vaccinated individuals had a similar amount of virus presence as the unvaccinated, suggesting that, unlike with other variants, vaccinated people infected with the Delta variant could transmit the virus, the CDC said.

CDC Director Rochelle Walensky said this was a "pivotal discovery" leading to CDC's recommendation this week that masks be worn in areas where cases were surging as a precaution against possible transmission by fully vaccinated people.

"The masking recommendation was updated to ensure the vaccinated public would not unknowingly transmit virus to others, including their unvaccinated or immunocompromised loved ones," Walensky said.

The CDC said 469 cases were found among Massachusetts residents from July 3 to 26 related to the Cape Code outbreak. Of those, 74% were among fully vaccinated people. The CDC said its study excluded residents of 22 other states. Barnstable County reported that as of July 30, 934 total cases had been associated with the outbreak.

The CDC said that overall, 79% of the vaccinated individuals who were infected with COVID-19 also reported symptoms such as cough, headache, sore throat and fever. Four had to be hospitalized, the CDC said.

Vaccinated individuals had received one of the three available shots made by Pfizer Inc and BioNTech , Moderna Inc or Johnson & Johnson, the data showed.

The study's authors recommended local health authorities consider requiring masks in indoor public settings regardless of vaccination status or the number of cases in the community.

The CDC said that people with COVID-19 reported having been at densely packed indoor and outdoor events including bars, restaurants, guest houses and rental homes. (Reporting by Manas Mishra in Bengaluru; Editing by Howard Goller and Edmund Blair)


ę Reuters 2021
All news about MODERNA, INC.
08:29aWHITE HOUSE REPORTEDLY URGED PFIZER : NY Times
MT
12:17aIndia Unlikely to Order Pfizer, Moderna COVID-19 Jabs As Local Vaccine Output Soars
MT
09/21MODERNA : Brazil and Argentina tapped to make mRNA vaccines in Latin America
RE
09/21MODERNA : U.S. administers 386.8 mln doses of COVID-19 vaccines - CDC
RE
09/21MODERNA : U.S. CDC Says Delivered 467,249,715 Doses Of Covid-19 Vaccine As Of Sept 21
RE
09/21Shangula Rages Against West's Vaccine Nationalism
AQ
09/21Johnson & Johnson Data Shows COVID-19 Booster Shots 94% Effective Against Moderate to S..
MT
09/21EUROPEAN MIDDAY BRIEFING : Stocks Rebound But -3-
DJ
09/21NORTH AMERICAN MORNING BRIEFING : Markets Steady -2-
DJ
09/20MODERNA : U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 348 M - -
Net income 2021 12 529 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 14,6x
Yield 2021 -
Capitalization 175 B 175 B -
EV / Sales 2021 7,97x
EV / Sales 2022 7,37x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 434,04 $
Average target price 306,23 $
Spread / Average Target -29,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.315.47%175 199
LONZA GROUP AG33.09%60 866
IQVIA HOLDINGS INC.43.03%49 103
CELLTRION, INC.-23.26%31 708
SEAGEN INC.-5.78%30 021
PHARMARON BEIJING CO., LTD.83.56%25 723